NanoViricides Statistics
Total Valuation
NanoViricides has a market cap or net worth of $25.45 million. The enterprise value is $24.33 million.
Important Dates
The next estimated earnings date is Friday, February 13, 2026, after market close.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NanoViricides has 21.57 million shares outstanding. The number of shares has increased by 29.00% in one year.
| Current Share Class | 21.57M |
| Shares Outstanding | 21.57M |
| Shares Change (YoY) | +29.00% |
| Shares Change (QoQ) | +5.57% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 6.63% |
| Float | 20.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.89 |
| P/TBV Ratio | 3.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.06
| Current Ratio | 1.06 |
| Quick Ratio | 0.95 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -55,171.11 |
Financial Efficiency
Return on equity (ROE) is -94.03% and return on invested capital (ROIC) is -59.46%.
| Return on Equity (ROE) | -94.03% |
| Return on Assets (ROA) | -51.13% |
| Return on Invested Capital (ROIC) | -59.46% |
| Return on Capital Employed (ROCE) | -114.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.16M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.67% in the last 52 weeks. The beta is 1.24, so NanoViricides's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -1.67% |
| 50-Day Moving Average | 1.30 |
| 200-Day Moving Average | 1.41 |
| Relative Strength Index (RSI) | 47.12 |
| Average Volume (20 Days) | 278,713 |
Short Selling Information
The latest short interest is 458,440, so 2.13% of the outstanding shares have been sold short.
| Short Interest | 458,440 |
| Short Previous Month | 177,283 |
| Short % of Shares Out | 2.13% |
| Short % of Float | 2.19% |
| Short Ratio (days to cover) | 1.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.22M |
| Pretax Income | -8.13M |
| Net Income | -8.13M |
| EBITDA | -7.54M |
| EBIT | -8.22M |
| Earnings Per Share (EPS) | -$0.51 |
Full Income StatementBalance Sheet
The company has $1.13 million in cash and n/a in debt, with a net cash position of $1.13 million or $0.05 per share.
| Cash & Cash Equivalents | 1.13M |
| Total Debt | n/a |
| Net Cash | 1.13M |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 7.17M |
| Book Value Per Share | 0.41 |
| Working Capital | 70,180 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.48 million and capital expenditures -$94,517, giving a free cash flow of -$7.57 million.
| Operating Cash Flow | -7.48M |
| Capital Expenditures | -94,517 |
| Free Cash Flow | -7.57M |
| FCF Per Share | -$0.35 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
